Metabolic Syndrome and the Risk for Chronic Kidney Disease among Nondiabetic Adults
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The metabolic syndrome is a risk factor for the development of diabetes and cardiovascular disease; however, no prospective studies have examined the metabolic syndrome as a risk factor for chronic kidney disease (CKD). A total of 10,096 nondiabetic participants who were in the Atherosclerosis Risk in Communities study and had normal baseline kidney function composed the study cohort. The metabolic syndrome was defined according to recent guidelines from the National Cholesterol Education Program. Incident CKD was defined as an estimated GFR (eGFR) <60 ml/min per 1.73 m2 at study year 9 among those with an eGFR > or =60 ml/min per 1.73 m2 at baseline. After 9 yr of follow-up, 691 (7%) participants developed CKD. The multivariable adjusted odds ratio (OR) of developing CKD in participants with the metabolic syndrome was 1.43 (95% confidence interval [CI], 1.18 to 1.73). Compared with participants with no traits of the metabolic syndrome, those with one, two, three, four, or five traits of the metabolic syndrome had OR of CKD of 1.13 (95% CI, 0.89 to 1.45), 1.53 (95% CI, 1.18 to 1.98), 1.75 (95% CI, 1.32 to 2.33), 1.84 (95% CI, 1.27 to 2.67), and 2.45 (95% CI, 1.32 to 4.54), respectively. After adjusting for the subsequent development of diabetes and hypertension during the 9 yr of follow-up, the OR of incident CKD among participants with the metabolic syndrome was 1.24 (95% CI, 1.01 to 1.51). The metabolic syndrome is independently associated with an increased risk for incident CKD in nondiabetic adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The metabolic syndrome is also an independent indicator for chronic kidney disease [636] and may be related to liver steatosis [637].”
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Coresh, J., Astor, B. C., Greene, T., Eknoyan, G., & Levey, A. S. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50007 · Cited by 2,768
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
Chen, J., Muntner, P., Hamm, L. L., Jones, D. W., Batuman, V., Fonseca, V., Whelton, P. K., & He, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-3-200402030-00007 · Cited by 1,359
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Cited by
Items 101–200 of 719
Massy, Z. A., & Drüeke, T. B. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.05.033 · Cited by 88
Metabolic risk factors and renal disease
Sowers, J. R. (2007) · Kidney International · doi:10.1038/sj.ki.5002006 · Cited by 85
Kwakernaak, A. J., Zelle, D. M., Bakker, S. J. L., & Navis, G. J. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012050460 · Cited by 85
Vegetarian diets and chronic kidney disease
Chauveau, P., Koppe, L., Combe, C., Lasseur, C., Trolonge, S., & Aparicio, M. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy164 · Cited by 91
Low Urine pH Is a Predictor of Chronic Kidney Disease
Nakanishi, N., Fukui, M., Tanaka, M., Toda, H., Imai, S., Yamazaki, M., Hasegawa, G., Oda, Y., & Nakamura, N. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000330487 · Cited by 83
Physical Activity in the Prevention of Chronic Kidney Disease
Stump, C. S. (2011) · Cardiorenal Medicine · doi:10.1159/000329929 · Cited by 90
Relationship between chronic kidney disease and metabolic syndrome: current perspectives
Nashar, K., & Egan, B. M. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s45183 · Cited by 93
Animal Models of Diabetes-Associated Renal Injury
Noshahr, Z. S., Salmani, H., Rad, A. K., & Sahebkar, A. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9416419 · Cited by 98
Metabolic Syndrome, Proteinuria, and the Risk of Progressive CKD in Hypertensive African Americans
Lea, J. P., Cheek, D., Thornley-Brown, D., Appel, L. J., Agodoa, L. Y. C., Contreras, G. N., Gassman, J., Lash, J., Miller, E. R., Randall, O. S., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.013 · Cited by 82
Dissard, R., Klein, J., Caubet, C., Breuil, B., Siwy, J., Hoffman, J., Sicard, L., Ducassé, L., Rascalou, S., Payré, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076703 · Cited by 91
van Dijk, C. G. M., Oosterhuis, N. R., Xu, Y. J., Brandt, M., Paulus, W. J., van Heerebeek, L., Duncker, D. J., Verhaar, M. C., Fontoura, D., Lourenço, A. P., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002760 · Cited by 81
Smith, E. R., Lee, D., Cai, M. M., Tomlinson, L. A., Ford, M. L., McMahon, L. P., & Holt, S. G. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs586 · Cited by 81
Overweight, Obesity and Chronic Kidney Disease
Ting, S. M. S., Nair, H., Ching, I., Taheri, S., & Dasgupta, I. (2009) · Nephron Clinical Practice · doi:10.1159/000214206 · Cited by 88
Metabolic Syndrome and Kidney Disease
Ritz, E. (2008) · Blood Purification · doi:10.1159/000110566 · Cited by 84
Aldosterone and glomerular podocyte injury
Nagase, M., & Fujita, T. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-008-0034-9 · Cited by 82
Comorbidities and Metabolic Derangement of NAFLD
Bang, K. B., & Cho, Y. K. (2015) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2015.5.1.7 · Cited by 83
Nistala, R., Habibi, J., Aroor, A., Sowers, J. R., Hayden, M. R., Meuth, A., Knight, W., Hancock, T., Klein, T., DeMarco, V. G., et al. (2014) · Obesity · doi:10.1002/oby.20833 · Cited by 79
Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Mastrocola, R., Aragno, M., Alloatti, G., Collino, M., Penna, C., & Pagliaro, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170407123522 · Cited by 76
“As so far evidenced, dyslipidemia is the MS-related factor mainly responsible for cardiovascular risk and hepatic inflammation, while the role of lipid metabolism in the onset of CKD is still under debate.”
BackgroundInfluentialKang, H., Kim, S., Lee, G., Lee, I., Lee, J. P., Lee, J., Park, H., Moon, H.-B., Park, J., Kim, S., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.01.028 · Cited by 77
Sun, F., Tao, Q., & Zhan, S. (2010) · Nephrology · doi:10.1111/j.1440-1797.2009.01150.x · Cited by 80
Trirogoff, M. L., Shintani, A., Himmelfarb, J., & Ikizler, T. A. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1642 · Cited by 82
Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl204 · Cited by 82
Self-citationWeber, G. J., Pushpakumar, S. B., Tyagi, S. C., & Sen, U. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.002 · Cited by 79
Metabolic syndrome in hypertensive patients: An unholy alliance
Mulè, G., Calcaterra, I., Nardi, E., Cerasola, G., & Cottone, S. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i9.890 · Cited by 88
Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors.
Pluimakers, V., van Waas, M., Neggers, S., & van den Heuvel-Eibrink, M. M. (2019) · Critical reviews in oncology/hematology · doi:10.1016/j.critrevonc.2018.10.010 · Cited by 61
Niacin: an old lipid drug in a new NAD+ dress
Romani, M., Hofer, D. C., Katsyuba, E., & Auwerx, J. (2019) · Journal of Lipid Research · doi:10.1194/jlr.s092007 · Cited by 74
Wakasugi, M., Kazama, J. J., Yamamoto, S., Kawamura, K., & Narita, I. (2012) · Hypertension Research · doi:10.1038/hr.2012.186 · Cited by 74
Chronic kidney disease in United States Hispanics: a growing public health problem.
Lora, C. M., Daviglus, M. L., Kusek, J. W., Porter, A. C., Ricardo, A. C., Go, A. S., & Lash, J. P. (2009) · PubMed · Cited by 71
Hao, Z., Konta, T., Takasaki, S., Abiko, H., Ishikawa, M., Takahashi, T., Ikeda, A., Ichikawa, K., Kawata, S., Kato, T., et al. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6056 · Cited by 76
Insulin: Trigger and Target of Renal Functions
Pina, A. F., Borges, D. O., Meneses, M. J., Branco, P. Q., Birne, R., Vilasi, A. D., & Macedo, M. P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00519 · Cited by 68
Hu, Z., Ren, L., Wang, C., Liu, B., & Song, G. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000341485 · Cited by 69
Obesity, Cardiometabolic Syndrome, and Chronic Kidney Disease: The Weight of the Evidence
Lastra, G., Manrique, C. M., & Sowers, J. R. (2006) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.07.011 · Cited by 69
Obesity, insulin resistance and kidney disease risk: insights into the relationship
Sarafidis, P. A. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328305b994 · Cited by 70
Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials
Chan, D. T., Irish, A. B., Dogra, G. K., & Watts, G. F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.01.023 · Cited by 67
Mineralocorticoid receptor activation in obesity hypertension
Nagase, M., & Fujita, T. (2009) · Hypertension Research · doi:10.1038/hr.2009.86 · Cited by 72
Zmistowski, B. M., Dizdarevic, I., Jacovides, C. L., Radcliff, K. E., Mraović, B., & Parvizi, J. (2013) · The Journal of Arthroplasty · doi:10.1016/j.arth.2012.12.018 · Cited by 63
The Effect of Obesity on Chronic Kidney Disease
Kopple, J. D., & Feroze, U. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.10.009 · Cited by 71
Yu, M., Ryu, D., Kim, S., Choi, K.-B., & Kang, D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp483 · Cited by 68
Xie, K., Bao, L., Jiang, X., Ye, Z., Bing, J., Dong, Y., Gao, D., Ji, X., Jiang, T., Li, J., et al. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1121-5 · Cited by 63
Epidemiology of Obesity and Chronic Kidney Disease
Ross, W. R., & McGill, J. B. (2006) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2006.07.012 · Cited by 68
Stacchiotti, A., Favero, G., Giugno, L., Lavazza, A., Reiter, R. J., Rodella, L. F., & Rezzani, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111141 · Cited by 62
Kim, M., Paik, J. K., Kang, R., Kim, S. Y., Lee, S., & Lee, J. H. (2012) · Metabolism · doi:10.1016/j.metabol.2012.10.006 · Cited by 65
Impact of treating the metabolic syndrome on chronic kidney disease
Agrawal, V., Shah, A., Rice, C., Franklin, B. A., & McCullough, P. A. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.114 · Cited by 62
He, Y., Fan, L., Wang, F., Ma, X., Zhao, X., & Zeng, Q. (2016) · Medicine · doi:10.1097/md.0000000000003769 · Cited by 67
Metabolic syndrome and chronic kidney disease
Ruan, X. Z., & Guan, Y. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00042.x · Cited by 68
Prevention of Obesity-Induced Renal Injury in Male Mice by DPP4 Inhibition
Nistala, R., Habibi, J., Lastra, G., Manrique, C. M., Aroor, A. R., Hayden, M. R., Garro, M., Meuth, A. I., Johnson, M. S., Whaley‐Connell, A. T., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1920 · Cited by 63
Iorio, B. R. D., Micco, L. D., Marzocco, S., Simone, E. D., Blasio, A. D., Sirico, M. L., Nardone, L., & On behalf of UBI Study Group (2017) · Nutrients · doi:10.3390/nu9010069 · Cited by 60
Rashidi, A., Ghanbarian, A., & Azizi, F. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01020207 · Cited by 59
Correlates of insulin resistance in older individuals with and without kidney disease
Landau, M. S., Tamura, M. K., Shlipak, M. G., Kanaya, A. M., Strotmeyer, E. S., Koster, A., Satterfield, S., Simsonick, E., Goodpaster, B. H., Newman, A. B., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq817 · Cited by 61
Pathophysiological Links Between Diabetes and Blood Pressure
Libianto, R., Batu, D., MacIsaac, R. J., Cooper, M. E., & Ekinci, E. I. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.010 · Cited by 67
Watanabe, H., Obata, H., Watanabe, T., Sasaki, S., Nagai, K., & Aizawa, Y. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1058 · Cited by 62
Alizadeh, S., Ahmadi, M., Nejad, B. G., Djazayeri, A., & Shab‐Bidar, S. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13201 · Cited by 61
Historical perspectives of the metabolic syndrome
Oda, E. (2017) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.002 · Cited by 61
Cardiometabolic Syndrome and Chronic Kidney Disease: What Is the Link?
Sarafidis, P. A., Whaley‐Connell, A. T., Sowers, J. R., & Bakris, G. L. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.0197-3118.2006.05470.x · Cited by 63
Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed-a review
Garg, P., & Duggal, N. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100459 · Cited by 68
Cao, X., Zhou, J., Yuan, H., Wu, L., & Chen, Z. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0083-8 · Cited by 61
Seidu, S., Abdool, M., Almaqhawi, A., Wilkinson, T. J., Kunutsor, S. K., Khunti, K., & Yates, T. E. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-022-00961-7 · Cited by 57
Oh, Y. (2012) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2011.12.005 · Cited by 62
Chueakula, N., Jaikumkao, K., Arjinajarn, P., Pongchaidecha, A., Chatsudthipong, V., Chattipakorn, N., & Lungkaphin, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.11.021 · Cited by 60
Association of Vegetarian Diet with Chronic Kidney Disease
Liu, H.-W., Tsai, W., Liu, J., & Kuo, K. (2019) · Nutrients · doi:10.3390/nu11020279 · Cited by 56
Raimundo, M. R., & Lopes, J. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/747861 · Cited by 64
Metabolic Syndrome and Chronic Kidney Disease in a Chinese Population Aged 40 Years and Older
Zhang, L., Zuo, L., Wang, F., Wang, M., Wang, S., Liu, L., & Wang, H. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.7.822 · Cited by 61
Resolved: Being Fat Is Good for Dialysis Patients: The Godzilla Effect: Pro
Ikizler, T. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007090983 · Cited by 59
Metabolic Syndrome: Treatment of Hypertensive Patients
Israili, Z. H., Lyoussi, B., Hernández-Hernández, R., & Velasco, M. (2007) · American Journal of Therapeutics · doi:10.1097/01.pap.0000249936.05650.0c · Cited by 53
The association of genetic variants of type 2 diabetes with kidney function
Franceschini, N., Shara, N. M., Wang, H., Voruganti, V. S., Laston, S., Haack, K., Lee, E. T., Best, L. G., MacCluer, J. W., Cochran, B. J., et al. (2012) · Kidney International · doi:10.1038/ki.2012.107 · Cited by 57
Systemic inflammation, metabolic syndrome and progressive renal disease
Cirillo, P., Sautin, Y. Y., Kanellis, J., Kang, D., Gesualdo, L., Nakagawa, T., & Johnson, R. J. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp038 · Cited by 56
Relaxin Treatment Reverses Insulin Resistance in Mice Fed a High-Fat Diet
Bonner, J. S., Lantier, L., Hocking, K. M., Kang, L., Owolabi, M., James, F. D., Bracy, D. P., Brophy, C. M., & Wasserman, D. H. (2013) · Diabetes · doi:10.2337/db13-0033 · Cited by 52
“Macroangiopathies and microangiopathies correlate with insulin resistance (56,57) leading to impaired tissue perfusion, which is a key component of the etiology of diabetes-related tissue and organ damage (58).”
BackgroundHo, C.-I., Chen, J., Chen, S.-Y., Tsai, Y.-W., Weng, Y.-M., Tsao, Y.-C., & Li, W.-C. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.09.007 · Cited by 52
Hanai, K., Babazono, T., Nyumura, I., Toya, K., Ohta, M., Bouchi, R., Suzuki, K., Inoue, A., & Iwamoto, Y. (2009) · Clinical and Experimental Nephrology · doi:10.1007/s10157-009-0245-8 · Cited by 52
Metabolic syndrome severity score and the progression of CKD
Wu, M., Shu, Y., Wang, L., Song, L., Chen, S., Liu, Y., Bi, J., Li, D., Yang, Y., Hu, Y., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13646 · Cited by 52
Winfield, R. D., Delano, M. J., Dixon, D. J., Schierding, W. S., Cendan, J. C., Lottenberg, L. L., López, M. C., Baker, H. V., Cobb, J. P., Moldawer, L. L., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b08089 · Cited by 51
Kittiskulnam, P., Thokanit, N. S., Katavetin, P., Susanthitaphong, P., Srisawat, N., Praditpornsilpa, K., Tungsanga, K., & Eiam‐Ong, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196332 · Cited by 54
Obstructive sleep apnea and kidney disease: is there any direct link?
Mirrakhimov, A. E. (2011) · Sleep And Breathing · doi:10.1007/s11325-011-0624-8 · Cited by 55
Vinhas, J., Gardete-Correia, L., Boavida, J. M., Raposo, J. F., Mesquita, A. C., Fona, M. C., Carvalho, R., & Cardoso, S. M. (2011) · Nephron Clinical Practice · doi:10.1159/000324218 · Cited by 51
Aroor, A., McKarns, S., Nistala, R., DeMarco, V., Gardner, M., Garcia-Touza, M., Whaley-Connell, A., & Sowers, J. R. (2013) · Cardiorenal Medicine · doi:10.1159/000348756 · Cited by 49
Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study
DeBoer, M. D., Filipp, S. L., Musani, S. K., Sims, M., Okusa, M. D., & Gurka, M. J. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000488829 · Cited by 50
Fan, Y.-Y., Kohno, M., Nakano, D., Ohsaki, H., Kobori, H., Diah, S., Ohashi, N., Hitomi, H., Asanuma, K., Noma, T., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328336ade3 · Cited by 49
Role of NADPH Oxidase in Metabolic Disease‐Related Renal Injury: An Update
Wan, C., Su, H., & Zhang, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7813072 · Cited by 52
Association between metabolic syndrome and chronic kidney disease in a Chinese urban population
Chen, J., Kong, X., Jia, X., Li, W., Wang, Z., Cui, M., & Xu, D. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.05.012 · Cited by 48
Nakhaei, H., Mogharnasi, M., & Fanaei, H. (2019) · Obesity Medicine · doi:10.1016/j.obmed.2019.100111 · Cited by 51
Role of Podocytes in Focal Sclerosis: Defining the Point of No Return
Kretzler, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080841 · Cited by 48
Huang, X., Sjögren, P., Ärnlöv, J., Cederholm, T., Lind, L., Stenvinkel, P., Lindholm, B., Risérus, U., & Carrero, J. J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12130 · Cited by 50
Zhang, J., Jiang, H., & Chen, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10915 · Cited by 47
Chen, S., Chen, Y., Liu, X., Li, M., Wu, B., Li, Y., Liang, Y., Shao, X., Holthöfer, H., & Zou, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074058 · Cited by 49
Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?
Zoccali, C., & Kielstein, J. T. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000222701.22583.e8 · Cited by 53
Kunutsor, S. K., Seidu, S., Kurl, S., & Laukkanen, J. A. (2024) · GeroScience · doi:10.1007/s11357-023-01044-5 · Cited by 45
Nagase, M. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0298-8 · Cited by 46
Gu, S., Wang, A., Ning, G., Zhang, L., & Mu, Y. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.13010 · Cited by 46
Su, W., Chen, I.-H., Gau, Y., Wu, P.-Y., Huang, J., Tsai, Y., Chen, S., Chang, J., Hwang, S., & Chen, H. (2022) · Biomedicines · doi:10.3390/biomedicines10071744 · Cited by 47
Al‐Qaoud, T., Nitsch, D., Wells, J. C. K., Witte, D. R., & Brunner, E. J. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.04.017 · Cited by 48
Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children
Lalan, S. P., Jiang, S., Ng, D. K., Kupferman, F., Warady, B. A., Furth, S. L., & Mitsnefes, M. M. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.06.007 · Cited by 44
Gobal, F. A., Deshmukh, A. J., Shah, S. V., & Mehta, J. L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.027 · Cited by 56
Long-Term Patient Survival: Strategies to Improve Overall Health
Adams, P. L. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.043 · Cited by 44
Lee, J. E., Choi, S. Y., Huh, W., Kim, Y.-G., Kim, D. J., & Oh, H. Y. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.04.020 · Cited by 45
Yang, M., Liu, C., Jiang, J., Zuo, G., Lin, X., Yamahara, J., Wang, J., & Li, Y. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-174 · Cited by 46
Athyros, V. G., Karagiannis, A. I., Ganotakis, E. S., Paletas, K., Nicolaou, V., Bacharoudis, G. P., Τζιόμαλος, Κ., Alexandrides, T. K., Liberopoulos, E. N., Mikhailidis, D. P., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.595782 · Cited by 49
Kim, H. J., Lee, J., Chae, D., Lee, K., Sung, S. A., Yoo, T., Han, S. H., Ahn, C., & Oh, K. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1297-y · Cited by 42
Chang, H., Lee, P., Lei, C., Tung, C., Hsu, Y., Huang, T., Lu, L.-C., & Lin, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061450 · Cited by 42
Jang, S. Y., Kim, I., Ju, E. Y., Ahn, S. J., Kim, D., & Lee, S. W. (2010) · Journal of Public Health · doi:10.1093/pubmed/fdp127 · Cited by 43
Kors, L., Rampanelli, E., Stokman, G., Butter, L. M., Held, N. M., Claessen, N., Larsen, P. W. B., Verheij, J., Zuurbier, C. J., Liebisch, G., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.003 · Cited by 51
Metadata
- Authors
- Kurella, M., Lo, J. C., & Chertow, G. M.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-07
- Volume
- 16
- Issue
- 7
- Pages
- 2134-2140
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2107279414
- Cited by
- 709
- References
- 43
- Citations by year
- 2026: 5 · 2025: 18 · 2024: 23 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 30 · 2018: 29 · 2017: 24 · 2016: 31 · 2015: 35 · 2014: 45 · 2013: 42 · 2012: 42
- FWCI
- 27.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (N01DK12450)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K12AR047659, K12 AR47659)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic syndrome, chronic kidney disease, non-diabetic adults, estimated glomerular filtration rate, incident CKD risk, Atherosclerosis Risk in Communities Study, diabetes mellitus, hypertension, cardiovascular risk factors
- MeSH terms
- Chronic Disease, Diabetes Mellitus, Female, Humans, Kidney Diseases, Male, Middle Aged, Risk Factors, Incidence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.